---
title: "ALLOUCHE CYRIL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/31d2bf2d-be3f-5cd0-98c0-b3401066e970
json: https://whiteintel.dev/api/public/dossier/31d2bf2d-be3f-5cd0-98c0-b3401066e970
identifier: sec:0001744573
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ALLOUCHE CYRIL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001744573`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/31d2bf2d-be3f-5cd0-98c0-b3401066e970  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/31d2bf2d-be3f-5cd0-98c0-b3401066e970  

## Ownership & control

### Holdings / subsidiaries

- **Revance Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/d27d1b8c-a7b0-599e-8412-40f54f03e80a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ALLOUCHE CYRIL**. Human view: https://whiteintel.dev/entity/31d2bf2d-be3f-5cd0-98c0-b3401066e970 · Structured JSON: https://whiteintel.dev/api/public/dossier/31d2bf2d-be3f-5cd0-98c0-b3401066e970._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._